ID

42480

Descripción

Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3); ODM derived from: https://clinicaltrials.gov/show/NCT02248012

Link

https://clinicaltrials.gov/show/NCT02248012

Palabras clave

Versiones (1)
  1. 17/7/21 17/7/21 -
Titular de derechos de autor

Haukeland University Hospital Skane University Hospital Copenhagen University Hospital, Denmark Rigshospitalet, Denmark Uppsala University Hospital Aarhus University Hospital Sahlgrenska University Hospital, Sweden Ullevaal University Hospital

Subido en

17 de julio de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Neuroendocrine Carcinoma NCT02248012

Inglés

Eligibility Neuroendocrine Carcinoma NCT02248012

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven neuroendocrine carcinoma with a ki67 of 20-55%.primary gastroenteropancreatic tumor or cancer of unknown primary where metastases are mainly abdominal measurable disease according to recist by ct/mr
Descripción

Neuroendocrine Carcinoma, Ki67 Measurement | Primary gastroenteropancreatic tumor | Cancer of unknown primary where metastasis are mainly abdominal measurable according to CT/MR

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0206695
UMLS CUI [1,2]
C4049944
UMLS CUI [2,1]
C0475447
UMLS CUI [2,2]
C0017189
UMLS CUI [2,3]
C0030274
UMLS CUI [3,1]
C0027667
UMLS CUI [3,2]
C0027627
UMLS CUI [3,3]
C1513041
UMLS CUI [3,4]
C1542147
UMLS CUI [3,5]
C0017189
UMLS CUI [3,6]
C0024485
UMLS CUI [3,7]
C0040405
>18 years;
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
who/ecog performance status 0-1.
Descripción

Ecog performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
adequate haematological, renal and hepatic functions:
Descripción

Adequate haematological, renal and hepatic functions

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
written informed consent prior to inclusion
Descripción

Informed consent, written

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
prior therapy:
Descripción

Prior therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514463
no prior chemotherapy treatment for advanced disease.
Descripción

Prior chemotherapy due to advanced disease absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0679246
UMLS CUI [1,4]
C0332197
adjuvant chemotherapy must have ended > 6 months before inclusion.
Descripción

Recent adjuvant chemotherapy absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0085533
UMLS CUI [1,2]
C0332185
UMLS CUI [1,3]
C0332197
prior or current history:
Descripción

Prior or current history

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0009488
no curatively resectable disease;
Descripción

Curatively resectable disease absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C1514888
UMLS CUI [1,3]
C1276305
UMLS CUI [1,4]
C0332197
no other serious illness or medical conditions (including: unstable angina, myocardial infarction within 6 months, unstable diabetes, immune suppression )
Descripción

Other serious illness or medical conditions absent | Unstable angina | Myocardial infarction within 6 months | Unstable diabetes | Immunosuppression

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C0027051
UMLS CUI [3,2]
C0332185
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0002965
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0342302
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C4048329
UMLS CUI [6,2]
C0332197
concomitant treatments :
Descripción

Concomitant treatments

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707479
no concomitant (or within 4 weeks before inclusion) administration of any other experimental drug;
Descripción

No concomitant administration of any other experimental drug

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C0332197
no other concurrent anti-cancer therapy.
Descripción

No concurrent anti-cancer therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205420
UMLS CUI [1,3]
C0332197
other :
Descripción

ID.16

Tipo de datos

boolean

not pregnant or breast feeding. fertile patients must use adequate contraceptives and fertile females must have a negative pregnancy test.
Descripción

Pregnancy absent | Breastfeeding absent | Fertile patients must use adequate contraceptives | Fertile females must have a negative pregnancy test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0015895
UMLS CUI [2]
C0009871
UMLS CUI [3,1]
C0015895
UMLS CUI [3,2]
C0009871
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0032976
UMLS CUI [4,3]
C0205160
Volver a la parte superior de la página

Similar models

Eligibility Neuroendocrine Carcinoma NCT02248012

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Neuroendocrine Carcinoma, Ki67 Measurement | Primary gastroenteropancreatic tumor | Cancer of unknown primary where metastasis are mainly abdominal measurable according to CT/MR
Item
histologically proven neuroendocrine carcinoma with a ki67 of 20-55%.primary gastroenteropancreatic tumor or cancer of unknown primary where metastases are mainly abdominal measurable disease according to recist by ct/mr
boolean
C0206695 (UMLS CUI [1,1])
C4049944 (UMLS CUI [1,2])
C0475447 (UMLS CUI [2,1])
C0017189 (UMLS CUI [2,2])
C0030274 (UMLS CUI [2,3])
C0027667 (UMLS CUI [3,1])
C0027627 (UMLS CUI [3,2])
C1513041 (UMLS CUI [3,3])
C1542147 (UMLS CUI [3,4])
C0017189 (UMLS CUI [3,5])
C0024485 (UMLS CUI [3,6])
C0040405 (UMLS CUI [3,7])
Age
Item
>18 years;
boolean
C0001779 (UMLS CUI [1])
Ecog performance status
Item
who/ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Adequate haematological, renal and hepatic functions
Item
adequate haematological, renal and hepatic functions:
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Informed consent, written
Item
written informed consent prior to inclusion
boolean
C0021430 (UMLS CUI [1])
Prior therapy
Item
prior therapy:
boolean
C1514463 (UMLS CUI [1])
Prior chemotherapy due to advanced disease absent
Item
no prior chemotherapy treatment for advanced disease.
boolean
C1514457 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0679246 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Recent adjuvant chemotherapy absent
Item
adjuvant chemotherapy must have ended > 6 months before inclusion.
boolean
C0085533 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Prior or current history
Item
prior or current history:
boolean
C0262926 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
Curatively resectable disease absent
Item
no curatively resectable disease;
boolean
C0027651 (UMLS CUI [1,1])
C1514888 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Other serious illness or medical conditions absent | Unstable angina | Myocardial infarction within 6 months | Unstable diabetes | Immunosuppression
Item
no other serious illness or medical conditions (including: unstable angina, myocardial infarction within 6 months, unstable diabetes, immune suppression )
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0027051 (UMLS CUI [3,1])
C0332185 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0002965 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0342302 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C4048329 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
Concomitant treatments
Item
concomitant treatments :
boolean
C1707479 (UMLS CUI [1])
No concomitant administration of any other experimental drug
Item
no concomitant (or within 4 weeks before inclusion) administration of any other experimental drug;
boolean
C2347852 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
No concurrent anti-cancer therapy
Item
no other concurrent anti-cancer therapy.
boolean
C0920425 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
ID.16
Item
other :
boolean
Pregnancy absent | Breastfeeding absent | Fertile patients must use adequate contraceptives | Fertile females must have a negative pregnancy test
Item
not pregnant or breast feeding. fertile patients must use adequate contraceptives and fertile females must have a negative pregnancy test.
boolean
C0015895 (UMLS CUI [1])
C0009871 (UMLS CUI [2])
C0015895 (UMLS CUI [3,1])
C0009871 (UMLS CUI [3,2])
C3831118 (UMLS CUI [4,1])
C0032976 (UMLS CUI [4,2])
C0205160 (UMLS CUI [4,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial